← Home / IQVIA HOLDINGS INC. (IQV)
Stock Analysis

IQVIA HOLDINGS INC. (IQV)

IQV
IQV · Healthcare • Life Sciences Services
261.64 +0.81%
Track IQV in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IQV price is:
52W Range Position
100%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-27 00:33 UTC
WOI Investment Thesis
Constructive
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Moderate / Positive / Healthy / Pressured
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
No reliable structural support level is currently available.
Not available
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
28
●
Financial Results
HIGH
IQV reports financial results
(the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
JUN
11
$
Debt Financing
HIGH
IQV debt financing update
(the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc.
8-K Filing • SEC EDGAR
JUN
4
◆
M&A
HIGH
IQV merger or acquisition update
Other Events On June 4, 2026, IQVIA Holdings Inc.
8-K Filing • SEC EDGAR
What's Driving IQV?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is moderate. Profitability is positive. Cash generation is healthy. Balance-sheet quality is pressured.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
72.9
Price Chart
IQV — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-26
Fair
Fair valuation
The earnings multiple is in a moderate range.
Market Cap
$42.7B
Company size
EV
$57.0B
Debt-adjusted value
P/E
32.3
Reasonable
P/S
2.5
Low sales multiple
P/B
6.9
Balanced
EV/Sales
3.4
Low sales multiple
EV/EBIT
25.8
Reasonable
P/FCF
19.9
Reasonable
FCF Yield
5.03%
Cash return
Not financial advice
Business Lens
Improving business, cash flow needs monitoring
Financial conditions require selective monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Positive
≈
Cash Flow
Healthy
⚖
Balance Sheet
Pressured
💵 Revenue
4.15B
≈ Moderate
📈 Net Income
275.00M
↗ Positive
🧮 EPS (Basic)
1.63
↗ Positive
IQVIA HOLDINGS INC.
Healthcare • Life Sciences Services
You Might Also Like